Home » US FDA Memo Backs Sanofi Heart Drug Multaq
US FDA Memo Backs Sanofi Heart Drug Multaq
An experimental drug from Sanofi-Aventis should be approved for delaying symptoms of atrial fibrillation and reducing hospitalization, a U.S. drug reviewer said in a memo.
CNN Money
CNN Money
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May